Johnson & Johnson (NYSE:JNJ)

143.81
Delayed Data
As of Nov 25
 -0.06 / -0.04%
Today’s Change
109.16
Today|||52-Week Range
157.00
-1.41%
Year-to-Date
Liquidia (LQDA) PAH Drug Gets FDA's Complete Response Letter
9:14am / Zacks.com - Paid Partner Content
Here's the Coronavirus Vaccine Maker That's Most Likely to Blow Past Pfizer and Moderna
Nov 20 / MotleyFool.com - Paid Partner Content
Why Moderna Is Less Risky Than You Think
7:18am / MotleyFool.com - Paid Partner Content
Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate
Nov 19 / Zacks.com - Paid Partner Content
3 Index Funds Perfect for Your IRA
7:01am / MotleyFool.com - Paid Partner Content
Major Indices Fall Despite Positive Coronavirus Vaccine Data
Nov 19 / Zacks.com - Paid Partner Content
3 Stocks to Help You Build Retirement Wealth
Nov 25 / MotleyFool.com - Paid Partner Content
3 ETFs Perfect for Robinhood Investors
Nov 19 / MotleyFool.com - Paid Partner Content
Merck Sales Hit Hardest by Pandemic
Nov 24 / GuruFocus News - Paid Partner Content
A Virologist Explains: mRNA Coronavirus Vaccines And What Investors Should Know
Nov 19 / MotleyFool.com - Paid Partner Content
Tweedy Browne Burns Oil Holdings in the 3rd Quarter
Nov 24 / GuruFocus News - Paid Partner Content
Is Moderna Still a Compelling Growth Play?
Nov 18 / MotleyFool.com - Paid Partner Content
Moderna Set to Sell 160 Million Coronavirus Vaccine Doses to EU
Nov 24 / MotleyFool.com - Paid Partner Content
What Gives Moderna's Coronavirus Vaccine an Edge?
Nov 18 / MotleyFool.com - Paid Partner Content
How Does AstraZeneca's COVID-19 Vaccine Data Compare to Others'?
Nov 24 / Zacks.com - Paid Partner Content
Glaxo (GSK) Candidate Gets Breakthrough Tag for HIV Prevention
Nov 18 / Zacks.com - Paid Partner Content
3 Coronavirus Vaccine Makers Near Finish Line in November
Nov 24 / Zacks.com - Paid Partner Content
Ternium, Virgin Galactic, Moderna, Pfizer and Johnson & Johnson highlighted as Zacks Bull and Bear of the Day
Nov 18 / Zacks.com - Paid Partner Content
Pennant Investors Exits Johnson & Johnson, Cuts Amazon
Nov 24 / GuruFocus News - Paid Partner Content
3 Surefire Stocks to Buy If the Market Crashes
Nov 18 / MotleyFool.com - Paid Partner Content
Ask A Virologist: How Does GlaxoSmithKline's Potential Coronavirus Vaccine Work?
Nov 24 / MotleyFool.com - Paid Partner Content
2 Great Dividend Stocks Whose Payouts Could Double
Nov 18 / MotleyFool.com - Paid Partner Content
Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine
Nov 24 / Zacks.com - Paid Partner Content
3 Stocks to Win Big as Race for Coronavirus Vaccine Heats Up
Nov 17 / Zacks.com - Paid Partner Content
3 Dividend Stocks to Buy on Sale
Nov 23 / MotleyFool.com - Paid Partner Content
3 Dividend Aristocrats That Could Make You Rich
Nov 17 / MotleyFool.com - Paid Partner Content
3 Top Value Stocks To Buy Right Now
Nov 23 / MotleyFool.com - Paid Partner Content
Vaccine Hopes Push Markets To Frothy Levels: Stocks To Watch
Nov 16 / Zacks.com - Paid Partner Content
2 Pick-and-Shovel COVID Vaccine Stocks to Watch
Nov 23 / MotleyFool.com - Paid Partner Content
J&J (JNJ) Expands BARDA Deal for COVID-19 Vaccine Development
Nov 16 / Zacks.com - Paid Partner Content
Top COVID Vaccine Stocks to Buy Now
Nov 22 / MotleyFool.com - Paid Partner Content
Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?
Nov 15 / MotleyFool.com - Paid Partner Content
Why Do Baby Boomers Love AT&T?
Nov 22 / MotleyFool.com - Paid Partner Content
Investors Wish They Could Vote These 2 Healthcare CEOs Out
Nov 15 / MotleyFool.com - Paid Partner Content
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
Nov 21 / MotleyFool.com - Paid Partner Content
Here's How to Boost Your Retirement Income With Zero Effort
Nov 14 / MotleyFool.com - Paid Partner Content
Is There Room for Latecomers to the COVID-19 Party?
Nov 21 / MotleyFool.com - Paid Partner Content
Why You Shouldn't Ignore Johnson & Johnson
Nov 14 / MotleyFool.com - Paid Partner Content
Where Will Vaxart Be in 1 Year?
Nov 21 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: PFE Coronavirus Data, FDA Emergency Tag for LLY COVID-19 Drug
Nov 13 / Zacks.com - Paid Partner Content
Is Johnson & Johnson (JNJ) a Suitable Pick for Value Investors?
Nov 20 / Zacks.com - Paid Partner Content
The vaccine news is great for most stocks -- unless you're Zoom
Nov 09 / CNN.com - Paid Partner Content
Pharma Stock Roundup: PFE COVID-19 Vaccine Final Analysis, FDA Updates & More
Nov 20 / Zacks.com - Paid Partner Content
Dow soars more than 800 points after Pfizer announces great news about its vaccine and Joe Biden declared victorious
Nov 09 / CNN.com - Paid Partner Content
Is Sorrento Therapeutics Stock a Buy?
Nov 20 / MotleyFool.com - Paid Partner Content